Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapy.
暂无分享,去创建一个
Stephen L. Abrams | Saverio Candido | Massimo Libra | Lucio Cocco | J. McCubrey | M. Libra | A. Martelli | L. Steelman | S. Candido | L. Cocco | S. L. Abrams | T. Fitzgerald | J. Polesel | M. Cervello | G. Montalto | Stephen L Abrams | Linda S Steelman | Kvin Lertpiriyapong | Timothy L Fitzgerald | Alberto M Martelli | Giuseppe Montalto | Melchiorre Cervello | Jerry Polesel | James A McCubrey | Linda S. Steelman | K. Lertpiriyapong
[1] M. Zanetti,et al. Lipocalin 2 in cancer: when good immunity goes bad. , 2012, Cancer letters.
[2] J. Quigley,et al. Tissue-Infiltrating Neutrophils Constitute the Major In Vivo Source of Angiogenesis-Inducing MMP-9 in the Tumor Microenvironment12 , 2014, Neoplasia.
[3] W. Herrington,et al. Neutrophil gelatinase-associated lipocalin in kidney transplantation: A review. , 2015, Transplantation reviews.
[4] Stephen L. Abrams,et al. Effects of Ectopic Expression of NGAL on Doxorubicin Sensitivity , 2012, Oncotarget.
[5] D. Bolignano,et al. Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene. , 2010, Cancer letters.
[6] R. Konrat,et al. Lipocalin Q83 reveals a dual ligand binding mode with potential implications for the functions of siderocalins. , 2011, Biochemistry.
[7] Li Yan,et al. The High Molecular Weight Urinary Matrix Metalloproteinase (MMP) Activity Is a Complex of Gelatinase B/MMP-9 and Neutrophil Gelatinase-associated Lipocalin (NGAL) , 2001, The Journal of Biological Chemistry.
[8] Haowen Jiang,et al. Over‐expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer , 2015, The Prostate.
[9] A. Leonardi,et al. The neutrophil gelatinase-associated lipocalin (NGAL), a NF-κB-regulated gene, is a survival factor for thyroid neoplastic cells , 2008, Proceedings of the National Academy of Sciences.
[10] Y. Kuwahara,et al. Oxidative stress induced lipocalin 2 gene expression: addressing its expression under the harmful conditions. , 2007, Journal of radiation research.
[11] J. McCubrey,et al. Increased NGAL (Lnc2) expression after chemotherapeutic drug treatment. , 2013, Advances in biological regulation.
[12] K. Suk,et al. Diverse functional roles of lipocalin-2 in the central nervous system , 2015, Neuroscience & Biobehavioral Reviews.
[13] Martin J. Mueller,et al. Arabidopsis lipocalins AtCHL and AtTIL have distinct but overlapping functions essential for lipid protection and seed longevity. , 2014, Plant, cell & environment.
[14] A. Kohda,et al. DNA element downstream of the κB site in the Lcn2 promoter is required for transcriptional activation by IκBζ and NF‐κB p50 , 2014, Genes to cells : devoted to molecular & cellular mechanisms.
[15] Michael R. Green,et al. A Cell-Surface Receptor for Lipocalin 24p3 Selectively Mediates Apoptosis and Iron Uptake , 2005, Cell.
[16] J. McCubrey,et al. Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivation , 2014, Oncotarget.
[17] Myung Ah Lee,et al. Wnt3a expression is associated with MMP-9 expression in primary tumor and metastatic site in recurrent or stage IV colorectal cancer , 2014, BMC Cancer.
[18] L. Duvillard,et al. A case–control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer , 2014, BMC Cancer.
[19] J. McCubrey,et al. Participation of the Calcium/Calmodulin-dependent Kinases in Hydrogen Peroxide-induced IκB Phosphorylation in Human T Lymphocytes* , 2002, The Journal of Biological Chemistry.
[20] K. Dorritie,et al. STAT transcription factors in normal and cancer stem cells. , 2014, Advances in biological regulation.
[21] A. Martelli,et al. Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells. , 2014, Advances in biological regulation.
[22] F. Aigner,et al. Upregulation of Neutrophil Gelatinase-Associated Lipocalin in Colorectal Cancer Predicts Poor Patient Survival: Reply , 2014, World Journal of Surgery.
[23] Aristotelis Tsirigos,et al. The autophagic tumor stroma model of cancer , 2010, Cell cycle.
[24] M. Sehested,et al. Neutrophil Gelatinase-Associated Lipocalin Is Up-Regulated in Human Epithelial Cells by IL-1β, but Not by TNF-α 1 , 2003, The Journal of Immunology.
[25] Stephen L. Abrams,et al. Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention , 2013, Leukemia.
[26] H. Sengeløv,et al. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. , 1993, The Journal of biological chemistry.
[27] T. Westbrook,et al. Tcf3 promotes cell migration and wound repair through regulation of lipocalin 2 , 2014, Nature Communications.
[28] Y. Zhang,et al. NGAL and NGALR overexpression in human hepatocellular carcinoma toward a molecular prognostic classification. , 2012, Cancer epidemiology.
[29] Stephen L. Abrams,et al. Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention , 2014, Oncotarget.
[30] R. Craven,et al. Neutrophil Gelatinase-associated Lipocalin (NGAL) Expression Is Dependent on the Tumor-associated Sigma-2 Receptor S2RPgrmc1* , 2012, The Journal of Biological Chemistry.
[31] J. Cuzick,et al. Altered Microenvironment Promotes Progression of Preinvasive Breast Cancer: Myoepithelial Expression of αvβ6 Integrin in DCIS Identifies High-risk Patients and Predicts Recurrence , 2013, Clinical Cancer Research.
[32] J. G. Teodoro,et al. Induction of Apoptosis by a Secreted Lipocalin That is Transcriptionally Regulated by IL-3 Deprivation , 2001, Science.
[33] C. Sibata,et al. Inhibition of the CaM-Kinases augments cell death in response to oxygen radicals and oxygen radical inducing cancer therapies in MCF-7 human breast cancer cells , 2006, Cancer biology & therapy.
[34] A. Jahanian-Najafabadi,et al. Lipocalin 2 decreases senescence of bone marrow-derived mesenchymal stem cells under sub-lethal doses of oxidative stress , 2014, Cell Stress and Chaperones.
[35] D R Flower,et al. The lipocalin protein family: structure and function. , 1996, The Biochemical journal.
[36] Stephen L. Abrams,et al. Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine , 2012, Cell cycle.
[37] S. K. Choudhuri,et al. Iron N-(2-hydroxy acetophenone) glycinate (FeNG), a non-toxic glutathione depletor circumvents doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo , 2012, BioMetals.
[38] Jae-Hyun Park,et al. Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance. , 2012, Cancer cell.
[39] K. Umezawa,et al. Novel approaches to target NF-κB and other signaling pathways in cancer stem cells. , 2014, Advances in biological regulation.
[40] J. McCubrey,et al. Current treatment strategies for inhibiting mTOR in cancer. , 2015, Trends in pharmacological sciences.
[41] Jialiang Hu,et al. Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases , 2007, Nature Reviews Drug Discovery.
[42] H. Erdjument-Bromage,et al. An iron delivery pathway mediated by a lipocalin. , 2002, Molecular cell.
[43] X. Huang,et al. Parthenolide, an inhibitor of the nuclear factor-κB pathway, ameliorates dextran sulfate sodium-induced colitis in mice. , 2012, International immunopharmacology.
[44] J. McCubrey,et al. Activation of the calcium/calmodulin-dependent protein kinases as a consequence of oxidative stress. , 2006, Antioxidants & redox signaling.
[45] C. Butterfield,et al. Lipocalin 2 is a novel regulator of angiogenesis in human breast cancer , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[46] B. Dormanesh,et al. RETRACTED ARTICLE: The value of U-NGAL expression as a potential prognostic biomarker in patients with renal cancer after neoadjuvant chemotherapy with cisplatin , 2016, Tumor Biology.
[47] J. Cowland,et al. Induction of Neutrophil Gelatinase-associated Lipocalin Expression by Co-stimulation with Interleukin-17 and Tumor Necrosis Factor-α Is Controlled by IκB-ζ but neither by C/EBP-β nor C/EBP-δ* , 2010, The Journal of Biological Chemistry.
[48] D. Richardson,et al. Iron chelators for the treatment of cancer. , 2012, Current medicinal chemistry.
[49] J. Cowland,et al. IL-1β-Specific Up-Regulation of Neutrophil Gelatinase-Associated Lipocalin Is Controlled by IκB-ζ1 , 2006, The Journal of Immunology.
[50] H. Jaafar,et al. Pattern of Collagen Fibers and Localization of Matrix Metalloproteinase 2 and 9 during Breast Cancer Invasion , 2014, Tumori.
[51] Jun Yang,et al. Neutrophil Gelatinase Associated Lipocalin is an Independent Predictor of Poor Prognosis in Cases of Papillary Renal Cell Carcinoma. , 2015, The Journal of urology.
[52] D. Bolignano,et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[53] I. Chu,et al. Lipocalin‐2 negatively modulates the epithelial‐to‐mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF‐beta1)/Lcn2/Twist1 pathway , 2013, Hepatology.
[54] R. Khokha,et al. Proteolysis during Tumor Cell Extravasation In Vitro: Metalloproteinase Involvement across Tumor Cell Types , 2013, PloS one.
[55] Qing Gao,et al. Interleukin 17A Promotes Gastric Cancer Invasiveness via NF-κB Mediated Matrix Metalloproteinases 2 and 9 Expression , 2014, PloS one.
[56] D. Richardson,et al. The iron-regulated metastasis suppressor NDRG1 targets NEDD4L, PTEN, and SMAD4 and inhibits the PI3K and Ras signaling pathways. , 2013, Antioxidants & redox signaling.
[57] T. Igarashi,et al. Neutrophil gelatinase‐associated lipocalin regulates gut microbiota of mice , 2016, Journal of gastroenterology and hepatology.
[58] D. Xirodimas,et al. Mechanism of hypoxia-induced NFκB , 2011 .
[59] A. Friedl,et al. Neutrophil Gelatinase-associated Lipocalin in Normal and Neoplastic Human Tissues. Cell Type-specific Pattern of Expression , 1999, The Histochemical Journal.
[60] Wenshuai He,et al. Up-regulation of miR-138 inhibits hypoxia-induced cardiomyocyte apoptosis via down-regulating lipocalin-2 expression , 2016, Experimental biology and medicine.
[61] T. Mak,et al. Lipocalin 2 performs contrasting, location-dependent roles in APCmin tumor initiation and progression , 2012, Oncogene.
[62] G. Frühbeck,et al. Up-regulation of the novel proinflammatory adipokines lipocalin-2, chitinase-3 like-1 and osteopontin as well as angiogenic-related factors in visceral adipose tissue of patients with colon cancer. , 2011, The Journal of nutritional biochemistry.
[63] Stephen L. Abrams,et al. Mutations and Deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascades Which Alter Therapy Response , 2012, Oncotarget.
[64] Chawnshang Chang,et al. Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling , 2014, Oncogene.
[65] R. Strong,et al. Iron Traffics in Circulation Bound to a Siderocalin (Ngal)-Catechol Complex , 2010, Nature chemical biology.
[66] N. Sousa,et al. From the periphery to the brain: Lipocalin-2, a friend or foe? , 2015, Progress in Neurobiology.
[67] I. Stamenkovic,et al. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. , 1999, Genes & development.
[68] G. Zalcman,et al. RhoA induces MMP-9 expression at CD44 lamellipodial focal complexes and promotes HMEC-1 cell invasion. , 2003, Experimental cell research.
[69] D. Richardson,et al. Resistance to the Antineoplastic Agent Gallium Nitrate Results in Marked Alterations in Intracellular Iron and Gallium Trafficking: Identification of Novel Intermediates , 2006, Journal of Pharmacology and Experimental Therapeutics.
[70] C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment , 2014, Breast Cancer Research.
[71] V. Čapkun,et al. Lipocalin‐2 and matrix metalloproteinase‐9 expression in high‐grade endometrial cancer and their prognostic value , 2015, Histopathology.
[72] Ian R. Drexler,et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. , 2005, The Journal of clinical investigation.
[73] L. Pusztai,et al. Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis. , 2009, Cancer research.
[74] Li Yan,et al. The Matrix Metalloproteinase-9/Neutrophil Gelatinase-Associated Lipocalin Complex Plays a Role in Breast Tumor Growth and Is Present in the Urine of Breast Cancer Patients , 2005, Clinical Cancer Research.
[75] B. Aggarwal,et al. Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer. , 2008, Cancer research.
[76] Yun Wu,et al. Relationships of lipocalin 2 with breast tumorigenesis and metastasis , 2011, Journal of cellular physiology.
[77] G. Rice,et al. Neutrophil gelatinase‐associated lipocalin (NGAL) an early‐screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor‐induced epithelio‐mesenchymal transition , 2007, International journal of cancer.
[78] Xiaohai Wang,et al. Endothelial Cells Enhance Prostate Cancer Metastasis via IL-6→Androgen Receptor→TGF-β→MMP-9 Signals , 2013, Molecular Cancer Therapeutics.
[79] Z. Werb,et al. New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.
[80] Jian Tang,et al. Effect of Inhibiting NGAL Gene Expression on A549 Lung Cancer Cell Migration and Invasion , 2015 .
[81] M. Zanetti,et al. ER stress drives Lipocalin 2 upregulation in prostate cancer cells in an NF-κB-dependent manner , 2011, BMC Cancer.
[82] M. Katan,et al. PLCɛ and the RASSF family in tumour suppression and other functions. , 2013, Advances in biological regulation.
[83] Louis B Harrison,et al. Impact of tumor hypoxia and anemia on radiation therapy outcomes. , 2002, The oncologist.
[84] N. Perkins,et al. Regulation of activity and function of the p52 NF-κB subunit following DNA damage , 2010, Cell cycle.
[85] D. Zurakowski,et al. Urinary Biomarkers Predict Brain Tumor Presence and Response to Therapy , 2008, Clinical Cancer Research.
[86] C. Denkert,et al. Neutrophil Gelatinase-Associated Lipocalin (NGAL) Predicts Response to Neoadjuvant Chemotherapy and Clinical Outcome in Primary Human Breast Cancer , 2012, PloS one.
[87] T. Mak,et al. Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[88] L. Cui,et al. Protective effects of neutrophil gelatinase-associated lipocalin on hypoxia/reoxygenation injury of HK-2 cells. , 2011, Transplantation proceedings.
[89] T. Inaba,et al. Roles of Bim in Apoptosis of Normal and Bcr-Abl-Expressing Hematopoietic Progenitors , 2004, Molecular and Cellular Biology.
[90] B. Porse,et al. Liver is the major source of elevated serum lipocalin‐2 levels after bacterial infection or partial hepatectomy: A critical role for IL‐6/STAT3 , 2015, Hepatology.
[91] N. Soleimani,et al. Association between neutrophil geletinase-associated lipocalin and iron deficiency anemia in children on chronic dialysis , 2014, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.
[92] T. Muta,et al. Crucial roles of binding sites for NF-κB and C/EBPs in IκB-ζ-mediated transcriptional activation , 2007 .
[93] K. Oda,et al. Matrix Metalloproteinase (MMP)-9 in Cancer-Associated Fibroblasts (CAFs) Is Suppressed by Omega-3 Polyunsaturated Fatty Acids In Vitro and In Vivo , 2014, PloS one.
[94] Cheng‐Yi Chen,et al. Thyroid hormone-mediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer , 2015, Oncotarget.
[95] Haixin Hong,et al. Neutrophil gelatinase-associated lipocalin protects renal tubular epithelial cells in hypoxia–reperfusion by reducing apoptosis , 2014, International Urology and Nephrology.
[96] E. Li,et al. Lipocalin 2 promotes the migration and invasion of esophageal squamous cell carcinoma cells through a novel positive feedback loop. , 2015, Biochimica et biophysica acta.
[97] J. McCubrey,et al. Calcium/calmodulin-dependent kinase I and calcium/calmodulin-dependent kinase kinase participate in the control of cell cycle progression in MCF-7 human breast cancer cells. , 2005, Cancer research.
[98] D. Richardson,et al. The metastasis suppressor, Ndrg-1: a new ally in the fight against cancer. , 2006, Carcinogenesis.
[99] S. Korsmeyer,et al. Survival factor-induced extracellular signal-regulated kinase phosphorylates BIM, inhibiting its association with BAX and proapoptotic activity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[100] N. Chavez-Tapia,et al. Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in lung adenocarcinoma , 2015, Tumor Biology.
[101] Dihua Yu,et al. Upregulation of neutrophil gelatinase-associated lipocalin by ErbB2 through nuclear factor-kappaB activation. , 2009, Cancer research.
[102] J. McCubrey,et al. Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer , 2014, Oncotarget.
[103] D. Richardson,et al. The iron-regulated metastasis suppressor, Ndrg-1: identification of novel molecular targets. , 2008, Biochimica et biophysica acta.
[104] I. Shmulevich,et al. NGAL decreases E-cadherin-mediated cell-cell adhesion and increases cell motility and invasion through Rac1 in colon carcinoma cells , 2009, Laboratory Investigation.
[105] R. Strong,et al. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. , 2002, Molecular cell.
[106] A. Favier,et al. Interactions between doxorubicin and the human iron regulatory system. , 2003, Biochimica et biophysica acta.
[107] D. Richardson,et al. Tuning Cell Cycle Regulation with an Iron Key , 2007, Cell cycle.
[108] M. Lindstrom,et al. Heterogeneous expression of the lipocalin NGAL in primary breast cancers , 1998, International journal of cancer.
[109] H. Verspaget,et al. Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer. , 2007, European journal of cancer.
[110] M. Moses,et al. Lipocalin 2: A multifaceted modulator of human cancer , 2009, Cell cycle.
[111] D. Zurakowski,et al. Lipocalin 2 promotes breast cancer progression , 2009, Proceedings of the National Academy of Sciences.
[112] A. Mellor,et al. Neutrophil Gelatinase-Associated Lipocalin: Its Response to Hypoxia and Association with Acute Mountain Sickness , 2013, Disease markers.
[113] G. Thomas,et al. GLI1 Confers Profound Phenotypic Changes upon LNCaP Prostate Cancer Cells That Include the Acquisition of a Hormone Independent State , 2011, PloS one.
[114] M. Seifert,et al. Neutrophil gelatinase-associated lipocalin and interleukin-10 regulate intramacrophage Chlamydia pneumoniae replication by modulating intracellular iron homeostasis , 2013, Immunobiology.
[115] S. Witkin,et al. Neutrophil gelatinase-associated lipocalin and innate immune responses to bacterial infections , 2015, Medical Microbiology and Immunology.
[116] A. Toker,et al. Signaling specificity in the Akt pathway in biology and disease. , 2014, Advances in biological regulation.
[117] Stephen L. Abrams,et al. Diverse roles of GSK-3: tumor promoter-tumor suppressor, target in cancer therapy. , 2014, Advances in biological regulation.
[118] Stephen L. Abrams,et al. Targeting breast cancer initiating cells: advances in breast cancer research and therapy. , 2014, Advances in biological regulation.
[119] A. Jahanian-Najafabadi,et al. Lipocalin-2-mediated upregulation of various antioxidants and growth factors protects bone marrow-derived mesenchymal stem cells against unfavorable microenvironments , 2013, Cell Stress and Chaperones.
[120] Karan P. Singh,et al. Family history of non-hematologic cancers among Waldenstrom macroglobulinemia patients: a preliminary study. , 2012, Cancer epidemiology.
[121] Virgilia Macias,et al. Prostate cancer outcome and tissue levels of metal ions , 2009, The Prostate.
[122] I. Papassotiriou,et al. Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease , 2009, BMC Cancer.
[123] M. Hermann,et al. Lipocalin‐2 as mediator of chemokine expression and granulocyte infiltration during ischemia and reperfusion , 2013, Transplant international : official journal of the European Society for Organ Transplantation.
[124] B. Greene,et al. Iron chelators in cancer chemotherapy. , 2004, Current topics in medicinal chemistry.
[125] T. Mak,et al. Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. , 2010, The Journal of clinical investigation.
[126] F. E. Bertrand,et al. NOTCH and PTEN in prostate cancer. , 2014, Advances in biological regulation.
[127] F. Torti,et al. Iron and cancer: more ore to be mined , 2013, Nature Reviews Cancer.
[128] E. Eisenmesser,et al. Extracellular Vesicles Secreted from Cancer Cell Lines Stimulate Secretion of MMP-9, IL-6, TGF-β1 and EMMPRIN , 2013, PloS one.
[129] H. Christofk,et al. Estrogen Receptor (ER)α-regulated Lipocalin 2 Expression in Adipose Tissue Links Obesity with Breast Cancer Progression* , 2014, The Journal of Biological Chemistry.
[130] H. Tschesche,et al. The human neutrophil lipocalin supports the allosteric activation of matrix metalloproteinases. , 2001, European journal of biochemistry.
[131] L. Zang,et al. Berberine Inhibits Human Hepatoma Cell Invasion without Cytotoxicity in Healthy Hepatocytes , 2011, PloS one.
[132] J. Barata,et al. IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia. , 2013, Advances in biological regulation.
[133] Susan M. Kilroy,et al. Tumor-Specific Urinary Matrix Metalloproteinase Fingerprinting: Identification of High Molecular Weight Urinary Matrix Metalloproteinase Species , 2008, Clinical Cancer Research.
[134] J. McCubrey,et al. Pancreatic cancer stem cells: association with cell surface markers, prognosis, resistance, metastasis and treatment. , 2014, Advances in biological regulation.
[135] R. Cardiff,et al. CD44v3,8–10 is involved in cytoskeleton‐mediated tumor cell migration and matrix metalloproteinase (MMP‐9) association in metastatic breast cancer cells , 1998 .
[136] Y. Furuichi,et al. A novel small-molecule inhibitor of NF-kappaB signaling. , 2008, Biochemical and biophysical research communications.
[137] Shun-Fa Yang,et al. Knockdown of lipocalin‐2 suppresses the growth and invasion of prostate cancer cells , 2013, The Prostate.
[138] J. S. Kim,et al. Ursolic acid inhibits nuclear factor-κB signaling in intestinal epithelial cells and macrophages, and attenuates experimental colitis in mice. , 2014, Life sciences.
[139] V. Sukhatme,et al. Lipocalin 2 Antagonizes the Proangiogenic Action of Ras in Transformed Cells , 2006, Molecular Cancer Research.
[140] P. Schjerling,et al. Possible CaMKK-dependent regulation of AMPK phosphorylation and glucose uptake at the onset of mild tetanic skeletal muscle contraction. , 2007, American journal of physiology. Endocrinology and metabolism.
[141] J. Barata,et al. PTEN and leukemia stem cells. , 2014, Advances in biological regulation.
[142] Zihua Hu,et al. Identification of Common Transcriptional Regulatory Elements in Interleukin-17 Target Genes* , 2006, Journal of Biological Chemistry.
[143] A. Friedl,et al. Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer , 2008, Breast Cancer Research and Treatment.
[144] S. Asuthkar,et al. Irradiation-induced angiogenesis is associated with an MMP-9-miR-494-syndecan-1 regulatory loop in medulloblastoma cells , 2014, Oncogene.
[145] Zhong-ying Shen,et al. Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion , 2006, Journal of Clinical Pathology.
[146] S. Batra,et al. Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia , 2008, British Journal of Cancer.
[147] Qing-Yuan Sun. Ndc80 complex: New evidence for the existence of spindle assembly checkpoint in mammalian oocyte meiosis , 2011, Cell cycle.
[148] Jayson A. Neil,et al. Deconstructing mTOR complexes in regulation of Glioblastoma Multiforme and its stem cells. , 2013, Advances in biological regulation.
[149] J. McCubrey,et al. The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells , 2015, Oncotarget.
[150] D. Richardson,et al. Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation. , 2004, Blood.
[151] M. Vitale,et al. Calcium/calmodulin-dependent protein kinase II (CaMKII) phosphorylates Raf-1 at serine 338 and mediates Ras-stimulated Raf-1 activation , 2012, Cell cycle.
[152] T. Shiozawa,et al. Lipocalin2 enhances the matrix metalloproteinase-9 activity and invasion of extravillous trophoblasts under hypoxia. , 2013, Placenta.
[153] Konstantinos Thalassinos,et al. Comparative analysis of interactions of RASSF1-10. , 2013, Advances in biological regulation.
[154] A. Look,et al. Downregulation of Bim, a Proapoptotic Relative of Bcl-2, Is a Pivotal Step in Cytokine-Initiated Survival Signaling in Murine Hematopoietic Progenitors , 2001, Molecular and Cellular Biology.
[155] Sushovan Guha,et al. The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. , 2012, Biochimica et biophysica acta.
[156] D. Richardson,et al. A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics , 2006, Proceedings of the National Academy of Sciences.
[157] R. Konrat,et al. The v-myc-induced Q83 Lipocalin Is a Siderocalin* , 2010, The Journal of Biological Chemistry.
[158] D. Cameron,et al. Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancer. , 2007, Gynecologic oncology.
[159] T. Ishigami,et al. Lipocalin-2 is associated with radioresistance in oral cancer and lung cancer cells. , 2013, International journal of oncology.